http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0249742-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b9c1f73d1f541b96b213e7a702a8c0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-56
filingDate 1988-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67d4b9147f7c11fff4e5030407e7de8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2487d983023a8a5da2cfb71c0452566
publicationDate 1990-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0249742-A
titleOfInvention Optically active fluorine-containing alpha-hydroxycyclopropane compound
abstract NEW MATERIAL:An optically active fluorine-containing α-hydroxycyclopropane compound expressed by formula I (R 1 and R 2 are 1-2C fluorine-substituted alkyl, 1-10C alkyl, 7-10C aralkyl or 6-10C aryl, provided that at least either of R 1 and R 2 is 1-2C fluorine-substituted alkyl). n EXAMPLE: (1R)-(+)-1-(trans-2-Phenylcyclopropyl)-2,2,2-trifluoroethanol. n USE: A raw material for esters, ethers and carboxylic acids used as an enzymic inhibitor, biologically active substance, anticancer agent and ferroelectric liquid crystal. n PREPARATION: For example, a compound, having triple bond and expressed by formula II is reduced to provide a compound expressed by formula III, which is then acylated to afford a compound expressed by formula IV. The resultant compound expressed by formula IV is further subjected to asymmetric hydrolysis using an enzyme to provide compounds expressed by formulas V and Va. The obtained compound expressed by formula V is then converted into cyclopropane to afford the compound expressed by formula I. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6096908-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100335134-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017213259-A1
priorityDate 1988-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235638939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68113909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14673428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235638937

Total number of triples: 22.